SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME
申请人:BlinkBio, Inc.
公开号:US20170202970A1
公开(公告)日:2017-07-20
Described herein are silicon based conjugates capable of delivering one or more payload moieties to a target cell or tissue. Contemplated conjugates may include a silicon-heteroatom core, one or more optional catalytic moieties, a targeting moiety that permits accumulation of the conjugate within a target cell or tissue, one or more payload moieties (e.g., a therapeutic agent or imaging agent), and two or more non-interfering moieties covalently bound to the silicon-heteroatom core.
Synthesis, characterization and ethylene oligomerization behavior of N-(2-alkyl-5,6,7-trihydroquinolin-8-ylidene)arylaminonickel(II) dichlorides
作者:Wenbin Chai、Jiangang Yu、Lin Wang、Xinquan Hu、Carl Redshaw、Wen-Hua Sun
DOI:10.1016/j.ica.2011.12.008
日期:2012.4
A series of N-(2-alkyl-5,6,7-trihydroquinolin-8-ylidene)arylaminonickel(II) dichloride complexes were synthesized in a one-pot reaction with nickel dichloride. All nickel complexes were characterized by elemental and spectroscopic analysis. The molecular structures of representative nickel complexes, as determined by the single crystal X-ray diffraction, are reported. All nickel complexes, when treated with ethylaluminium sesquichloride (Et3Al2Cl3), showed high activities (up to 1.1 x 10(6) g mol(-1) h(-1)) for ethylene oligomerization, with good thermal stability at 80 degrees C at 10 atm ethylene. The influence of the reaction parameters on the catalytic behavior was investigated for these nickel-based systems, including variation of Al/Ni molar ratio and reaction temperature. (C) 2011 Elsevier B.V. All rights reserved.